Interface Biosciences
Interface Bio
United States · $3.0M raised
- Business Model
- B2B
- Website
- interface.bio
- Total Funding
- $3.0M
- Last Round
- $3.0M SeedDec 2023
- Rounds
- 1
About
AI-enabled metabolomics-based drug discovery platform using microbiome natural products to treat inflammatory diseases.
Summary
Interface Biosciences is an Artificial Intelligence company based in United States. It has raised $3.0M in total across 1 round, most recently a $3.0M Seed round in Dec 2023. Investors include Pear VC and LongeVC.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2023
Investors
Similar Companies
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Global contract research organization providing comprehensive drug development and laboratory ser...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company